Strumento inattivo

Altre lingue CinCor Pharma, Inc.

Azioni

CINC

US17240Y1091

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Acquisition of CinCor Pharma complete	27/02/23
AstraZeneca Completes $1.8 Billion Acquisition of CinCor Pharma to Boost Cardiorenal Portfolio	24/02/23
AstraZeneca closes CinCor buy; Enhertu wins Chinese approval	24/02/23
AstraZeneca : acquisition de CinCor finalisée	24/02/23
CinCor Pharma : Acquisition/Asset Disposal - Form 8-K	24/02/23
CINCOR PHARMA, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/02/23
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from NASDAQ Composite Index	24/02/23
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from S&P Global BMI Index	24/02/23
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from S&P TMI Index	24/02/23
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from NASDAQ Biotechnology Index	23/02/23
Astrazeneca Finance And Holdings Inc. completed the acquisition of CinCor Pharma, Inc. from a group of shareholders.	23/02/23
CINCOR PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21/02/23
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat	21/02/23
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat	21/02/23
CinCor Pharma, Inc. Announces Completion of End-of-Phase 2 Meeting with U.S. Food and Drug Administration on Anticipated Phase 3 Program for Baxdrostat in Hypertension	21/02/23
4 minutos de mercados : Febrero 9-2023	09/02/23
4 minutos de mercados : Febrero 8-2023	08/02/23
4 minutos de mercados : Febrero 7-2023	07/02/23
4 minutos de mercados : Febrero 6-2023	06/02/23
4 minutos de mercados : Febrero 3-2023	03/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CinCor Pharma, Inc.

Azioni

CINC

US17240Y1091

Altre lingue

Filtri